Compare NSRX & BCHT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NSRX | BCHT |
|---|---|---|
| Founded | 2019 | N/A |
| Country | Israel | United States |
| Employees | N/A | 15 |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 53.5M | 61.7M |
| IPO Year | N/A | 2026 |
| Metric | NSRX | BCHT |
|---|---|---|
| Price | $2.78 | $2.25 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | ★ $20.50 | $15.00 |
| AVG Volume (30 Days) | ★ 125.0K | 108.3K |
| Earning Date | 03-20-2026 | 03-17-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $7.24 |
| Revenue Next Year | N/A | $7.10 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.60 | $2.10 |
| 52 Week High | $9.99 | $2.45 |
| Indicator | NSRX | BCHT |
|---|---|---|
| Relative Strength Index (RSI) | 25.26 | 47.06 |
| Support Level | N/A | $2.17 |
| Resistance Level | $6.39 | $2.43 |
| Average True Range (ATR) | 0.46 | 0.15 |
| MACD | -0.19 | -0.01 |
| Stochastic Oscillator | 0.77 | 57.14 |
Nasus Pharma Ltd is a clinical-stage specialty pharmaceutical company focused principally on the development of intranasal drugs to treat emergency medical conditions. It is engaged in developing a number of intranasal powder products based on its a microsphere technology, aimed at assisting patients in several acute emergency situations such as opioid overdose and anaphylactic shock. Its portfolio comprises a number of programs: Intranasal Naloxone completed pivotal study and Intranasal Epinephrine (phase 2) as well as a number of preclinical POC programs.
Birchtech Corp is a provider of specialty activated carbon technologies, delivering solutions for air and water purification. It provides patented and proprietary Sorbent Enhancement Additive (SEA) technologies for mercury emissions capture to the coal-fired utility sector, and is developing water purification technologies with a specialization on forever chemicals such as PFAS and PFOS. Geographically, the company derives all of its revenue from the United States.